Israeli biotechs merge

I reported previously (28th May) on Israeli biotech BiomX which develops treatments using human bacteria (microbiome).  BiomX has now acquired Israel’s RondinX, which has built a cutting-edge technology platform set to unlock the potential of microbiome therapeutics.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *